nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anlotinib optimizes anti-tumor innate immunity to potentiate the therapeutic effect of PD-1 blockade in lung cancer
|
Yang, Yinli |
|
|
69 |
12 |
p. 2523-2532 |
artikel |
2 |
Anti-tumor efficacy of plasmid encoding emm55 in a murine melanoma model
|
Bunch, Brittany L. |
|
|
69 |
12 |
p. 2465-2476 |
artikel |
3 |
A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastases
|
Jansen, Yanina |
|
|
69 |
12 |
p. 2589-2598 |
artikel |
4 |
A single-valent long-acting human CD47 antagonist enhances antibody directed phagocytic activities
|
Wu, Fenglan |
|
|
69 |
12 |
p. 2561-2569 |
artikel |
5 |
Carrying the torch & facing new challenges
|
Dong, Haidong |
|
|
69 |
12 |
p. 2411-2412 |
artikel |
6 |
Characterizing caspase-1 involvement during esophageal disease progression
|
Barber, Gillian |
|
|
69 |
12 |
p. 2635-2649 |
artikel |
7 |
Current trends in cancer immunotherapy: a literature-mining analysis
|
Pouliliou, Stamatia |
|
|
69 |
12 |
p. 2425-2439 |
artikel |
8 |
Dynamics of peripheral T cell clones during PD-1 blockade in non-small cell lung cancer
|
Zhang, Fan |
|
|
69 |
12 |
p. 2599-2611 |
artikel |
9 |
Factors associated with ocular adverse event after immune checkpoint inhibitor treatment
|
Kim, Yong Joon |
|
|
69 |
12 |
p. 2441-2452 |
artikel |
10 |
Functional effects of immune complexes formed between pembrolizumab and patient-generated anti-drug antibodies
|
Hock, Barry D. |
|
|
69 |
12 |
p. 2453-2464 |
artikel |
11 |
Histopathological growth patterns correlate with the immunoscore in colorectal cancer liver metastasis patients after hepatectomy
|
Liang, Jie-ying |
|
|
69 |
12 |
p. 2623-2634 |
artikel |
12 |
Increased IL-10+CD206+CD14+M2-like macrophages in alveolar lavage fluid of patients with small cell lung cancer
|
Hu, Xintong |
|
|
69 |
12 |
p. 2547-2560 |
artikel |
13 |
Increased Th17 activation and gut microbiota diversity are associated with pembrolizumab-triggered tuberculosis
|
Zhang, Yun-Bin |
|
|
69 |
12 |
p. 2665-2671 |
artikel |
14 |
Induction of systemic immune responses and reversion of immunosuppression in the tumor microenvironment by a therapeutic vaccine for cervical cancer
|
Che, Yuxin |
|
|
69 |
12 |
p. 2651-2664 |
artikel |
15 |
Multi-antigen DNA vaccine delivered by polyethylenimine and Salmonella enterica in neuroblastoma mouse model
|
Stegantseva, Maria V. |
|
|
69 |
12 |
p. 2613-2622 |
artikel |
16 |
Pretreatment body mass index and clinical outcomes in cancer patients following immune checkpoint inhibitors: a systematic review and meta-analysis
|
Chen, Haizhu |
|
|
69 |
12 |
p. 2413-2424 |
artikel |
17 |
Prognostic impacts of tumoral expression and serum levels of PD-L1 and CTLA-4 in colorectal cancer patients
|
Omura, Yusuke |
|
|
69 |
12 |
p. 2533-2546 |
artikel |
18 |
The adjuvant effect of melanin is superior to incomplete Freund’s adjuvant in subunit/peptide vaccines in mice
|
Cuzzubbo, Stefania |
|
|
69 |
12 |
p. 2501-2512 |
artikel |
19 |
The role of myeloid-derived suppressor cells in increasing cancer stem-like cells and promoting PD-L1 expression in epithelial ovarian cancer
|
Komura, Naoko |
|
|
69 |
12 |
p. 2477-2499 |
artikel |
20 |
TIM-3 blockade combined with bispecific antibody MT110 enhances the anti-tumor effect of γδ T cells
|
Guo, Qingming |
|
|
69 |
12 |
p. 2571-2587 |
artikel |
21 |
Variation in neutrophil to lymphocyte ratio (NLR) as predictor of outcomes in metastatic renal cell carcinoma (mRCC) and non-small cell lung cancer (mNSCLC) patients treated with nivolumab
|
Simonaggio, A. |
|
|
69 |
12 |
p. 2513-2522 |
artikel |